>> Top Page >> Company Profile >> Company History May 8, 2003 GreenPeptide Co., Ltd. was founded. April 1, 2005 ImmunoDia Co., Ltd. was founded as an affiliated company. October 2005 The world first personalized peptide vaccine phase I trial for glioblastoma begins. November 2005 A personalized peptide vaccine phase I trial for hormone-refractory and recurrent prostate cancer begins. 1992 Genetic Analysis/Peptide Identification Identified more than 200 HLA class I-restricted CTL epitopic peptides and over 100 genes. 1998 - Translational Research Research to confirm peptide safety and efficacy begins at Kurume University. 2003 - GreenPeptide Co., Ltd. was founded. A drug discovery venture company set up with core technologies based on clinical research conducted at Kurume University. Pharmaceutical development using peptides begins, with providing "Optimized Treatment for Each Individual"as the ultimate goal. 2005 - ImmunoDia Co., Ltd. was founded as an affiliated company. This company specializes in diagnosis and testing, and performs an indispensable role in providing ""Optimized Treatment for Each Individual".